Clinical Trial Update: A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 clinical trial evaluating Lebrikizumab in participants with uncontrolled asthma on inhaled corticosteroids and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Lebrikizumab (lebrikizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Asthma | Phase 3 | Status: COMPLETED